The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Effect of Partial Ileal Bypass Surgery on Mortality and Morbidity from Coronary Heart Disease in Patients with Hypercholesterolemia: Report of the Program on the Surgical Control of the Hyperlipidemias (POSCH)
Open accessAbstract
BACKGROUND AND METHODS: The Program on the Surgical Control of the Hyperlipidemias (POSCH), a randomized clinical trial, was designed to test whether cholesterol lowering induced by the partial ileal bypass operation would favorably affect overall mortality or mortality due to coronary heart disease. The study population consisted of 838 patients (417 in the control group and 421 in the surgery group), both men (90.7 percent) and women, with an average age of 51 years, who had survived a first myocardial infarction. The mean follow-up period was 9.7 years. RESULTS: When compared with the control group at five years, the surgery group had a total plasma cholesterol level 23.3 percent lower (4.71 +/- 0.91 vs. 6.14 +/- 0.89 mmol per liter [mean +/- SD]; P less than 0.0001), a low-density lipoprotein cholesterol level 37.7 percent lower (2.68 +/- 0.78 vs. 4.30 +/- 0.89 mmol per liter; P less than 0.0001), and a high-density lipoprotein cholesterol level 4.3 percent higher (1.08 +/- 0.26 vs. 1.04 +/- 0.25 mmol per liter; P = 0.02). Overall mortality and mortality due to coronary heart disease were reduced, but not significantly so (deaths overall [control vs. surgery], 62 vs. 49, P = 0.164; deaths due to coronary disease, 44 vs. 32, P = 0.113). The overall mortality in the surgery subgroup with an ejection fraction greater than or equal to 50 percent was 36 percent lower (control vs. surgery, 39 vs. 24; P = 0.021). The value for two end points combined--death due to coronary heart disease and confirmed nonfatal myocardial infarction--was 35 percent lower in the surgery group (125 vs. 82 events; P less than 0.001). During follow-up, 137 control-group and 52 surgery-group patients underwent coronary-artery bypass grafting (P less than 0.0001). A comparison of base-line coronary arteriograms with those obtained at 3, 5, 7, and 10 years consistently showed less disease progression in the surgery group (P less than 0.001). The most common side effect of partial ileal bypass was diarrhea; others included occasional kidney stones, gallstones, and intestinal obstruction. CONCLUSIONS: Partial ileal bypass produces sustained improvement in the blood lipid patterns of patients who have had a myocardial infarction and reduces their subsequent morbidity due to coronary heart disease. The role of this procedure in the management of hypercholesterolemia remains to be determined. These results provide strong evidence supporting the beneficial effects of lipid modification in the reduction of atherosclerosis progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Specifically, each 1-mmol/L reduction in LDL-C was associated with an RR of 0.75 (95% CI, 0.66-0.86;P = .002)in major vascular events”
From Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions: A Systematic Review and Meta-analysis (2016) · cites this paper as [51]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1972) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1972.tb00899.x · Cited by 39,793
Practical Nonparametric Statistics
Groggel, D. J., & Conover, W. J. (2000) · Technometrics · doi:10.2307/1271101 · Cited by 11,076
Immunochemical quantitation of antigens by single radial immunodiffusion
Mancini, G., Carbonara, A. O., & Heremans, J. F. (1965) · Immunochemistry · doi:10.1016/0019-2791(65)90004-2 · Cited by 9,091
Hubert, H. B., Feinleib, M., McNamara, P. M., & Castelli, W. P. (1983) · Circulation · doi:10.1161/01.cir.67.5.968 · Cited by 4,241
Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with Dyslipidemia
Frick, M. H., Elo, O., Haapa, K., Heinonen, O. P., Heinsalmi, P., Helo, P., Huttunen, J. K., Kaitaniemi, P., Koskinen, P., Manninen, V., et al. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711123172001 · Cited by 3,881
A Generalized Wilcoxon Test for Comparing Arbitrarily Singly-Censored Samples
Gehan, E. A. (1965) · Biometrika · doi:10.1093/biomet/52.1-2.203 · Cited by 3,407
Incidence of Coronary Heart Disease and Lipoprotein Cholesterol Levels
Castelli, W. P. (1986) · JAMA · doi:10.1001/jama.256.20.2835 · Cited by 2,512
Peto, R., Pike, M. C., Armitage, P., Breslow, N. E., Cox, D. R., Howard, S. V., Mantel, N., McPherson, K., Peto, J., & Smith, P. G. (1976) · British Journal of Cancer · doi:10.1038/bjc.1976.220 · Cited by 2,294
Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study.
Kannel, W., Castelli, W., Gordon, T., & McNamara, P. M. (2020) · Annals of Internal Medicine · doi:10.7326/0003-4819-74-1-1 · Cited by 2,160
Research works printed but not linked: 29
- 10.1001/jama.256.20.2823 · DOI · Paper page
- Leren, 1966, Acta Med Scand Suppl, 466, 1
- 1968, Lancet, 2, 693
- Frantz, 1975, Circulation, 52, II-4
- 10.1001/jama.231.4.360 · DOI
- 10.1001/jama.251.3.351 · DOI · Paper page
- 10.1001/jama.257.23.3233 · DOI
- Buchwald H. Intestinal bypass for hypercholesterolemia. In: Nyhus LM, Baker RJ, eds. Mastery of surgery. Vol. 3. Boston: Little, Brown, 1984:901–7.
- Buchwald H, Campos CT. Partial ileal bypass for control of hyperlipidemia and atherosclerosis. In: Sabiston DC Jr, Spencer FC, eds. Surgery of the chest. 5th ed. Philadelphia: W.B. Saunders, 1990:1799–819.
- Schouten, 1986, Artery, 13, 240
- 1959, Stat Bull Metrop Life Insur Co, 40, 1
- Bruce, 1971, Ann Clin Res, 3, 323
- National Heart and Lung Institute, Lipid Research Clinics Program. Manual of laboratory operations. Vol. 1. Bethesda, Md.: National Institutes of Health, 1974. (DHEW publication no. (NIH) 75–628.)
- 1970, Bull World Health Organ, 43, 891
- Mantel, 1966, Cancer Chemother Rep, 50, 163
- Matts, Controlled Clin Trials
- Campos, 1987, Surgery, 102, 424
- Campos, 1988, Curr Surg, 45, 380
- Campos, 1988, Surg Forum, 39, 193
- Addison, 1851, Guys Hosp Rep, 2, 267
- Ignatovski, 1908, Izviest Imp Voyenno-med Akad S Petersb, 16, 154
- Anitschkow, 1913, Centralbl Allg Pathol Pathol Anat, 24, 1
- Wacker, 1913, Münchener Med Wochenschr, 60, 2097
- European Coronary Surgery Study Group, 1982, Lancet, 2, 1173
- Buchwald, 1965, Surgery, 58, 22
- Scott, 1967, Surg Gynecol Obstet, 125, 3
- Buchwald, 1963, Circulation, 28, II-649
- Moore, 1969, Surgery, 65, 98
- Buchwald, Ann Surg
Cited by
Sorted by citations
Items 801–900 of 1,000
Prevention of occult atherosclerotic disease
Parker, B. M., & Mukerji, V. (1991) · Developments in cardiovascular medicine · doi:10.1007/978-94-011-3404-0_24 · Cited by 1
Lipid Lowering: Progression and Regression of Atherosclerotic Lesions
Blankenhorn, D. H. (1993) · Medical science symposia series · doi:10.1007/978-94-011-1703-6_29 · Cited by 1
Bile Acid Induced Diarrhoea Pathophysiological and Clinical Aspects
Bajor, A. (2008) · Gothenburg University Publications Electronic Archive (Gothenburg University) · Cited by 1
Atherosclerosis: Risk Factors and Medical Management
DePalma, R. G., & Hayes, V. W. (2005) · Vascular Surgery · doi:10.1002/9780470987094.ch37 · Cited by 1
The Influence of Nifedipine on the Progression of Coronary Artery Disease in Man: The INTACT Study
INTACT Study Group, Lichtlen, P. R., Rafflenbeul, W., Nikutta, P., Jost, S., & Wiese, B. (1991) · Springer eBooks · doi:10.1007/978-3-642-85498-9_23 · Cited by 1
Early arterial disease of the lower extremities in diabetes : diagnostic evaluation and risk markers
Sahli, D. (2009) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 1
De la chirurgie de l’obésité à la chirurgie du diabète
Caiazzo, R. J., Arnalsteen, L., & Pattou, F. N. (2010) · Obésité · doi:10.1007/s11690-010-0247-4 · Cited by 1
Terrin, M. L. (1997) · Controlled Clinical Trials · doi:10.1016/s0197-2456(97)00021-4 · Cited by 1
Reversal of Atherosclerosis with Therapy: Update of Coronary Angiographic Trials
Hodis, H. N. (1996) · Advances in pharmacology · doi:10.1016/s1054-3589(08)60279-3 · Cited by 1
Comment on 'The great cholesterol myth: unfortunate consequences of Brown and Goldstein's mistake'
Miller, J. P. (2011) · QJM · doi:10.1093/qjmed/hcr250 · Cited by 1
Future approaches to reducing low-density lipoprotein cholesterol
Wierzbicki, A. S. (2006) · Future Lipidology · doi:10.2217/17460875.1.4.463 · Cited by 1
Alderman, E. L. (1992) · Atherosclerosis · doi:10.1016/0021-9150(92)90168-g · Cited by 1
Jones, P. H. (1996) · Endocrine Practice · doi:10.4158/ep.2.1.30 · Cited by 1
Sniderman, A. D. (1993) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(93)90135-n · Cited by 1
Rationale for Cholesterollowering Strategies
Grundy, S. M., & Friedman, D. E. (1995) · Current Problems in Cardiology · doi:10.1016/s0146-2806(06)80016-2 · Cited by 1
Thompson, G. R. (1993) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1993.tb00510.x · Cited by 1
Oliver, M. (1996) · ACC Current Journal Review · doi:10.1016/1062-1458(96)00053-0
Effects of Rosuvastatin on Oxidized-LDL Cholesterol in the Elderly
Ono, K., & Takaishi, M. (2009) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.e778 · Cited by 1
Asimakopoulos, G., Barlow, C. W., & Pillai, R. (1998) · Postgraduate Medical Journal · doi:10.1136/pgmj.74.869.157 · Cited by 1
Target Levels for Low-Density Lipoprotein in Patients With Coronary Heart Disease
Bloomfield, H. E. (1994) · JAMA · doi:10.1001/jama.1994.03510260025011 · Cited by 1
Raising HDL-C: back to the future?
Wierzbicki, A. S. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01412.x · Cited by 1
Zowall, H., & Grover, S. A. (2003) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1586/14737167.3.3.273 · Cited by 1
Lipid-lowering therapy — Implications for the prevention of atherosclerosis
Schmitz, G., & Lackner, K. J. (1994) · Steinkopff eBooks · doi:10.1007/978-3-642-85660-0_16 · Cited by 1
Dissent “Consider what a long way you've come” —The white queen to Alice
HIGGINS, M. W., & Lenfant, C. J. M. (1993) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(93)90134-m · Cited by 1
Health Promoting Medications in Older People
Guthridge, J. M., & Flicker, L. A. (1999) · Journal of Pharmacy Practice and Research · doi:10.1002/jppr1999295273 · Cited by 1
Peters, W. L. (1991) · Postgraduate Medicine · doi:10.1080/00325481.1991.11701085 · Cited by 1
An evaluation of two compact analyzers used for lipid analysis.
McKenney, J. M., Fary, D. F., Miller, G., Proctor, J. D., & Chinchili, V. M. (1993) · PubMed · Cited by 1
Sandison, A., & Taylor, P. (1997) · International journal of clinical practice · doi:10.1111/j.1742-1241.1997.tb11467.x · Cited by 1
Reversing coronary atherosclerosis
Kahn, J. K. (1993) · Postgraduate Medicine · doi:10.1080/00325481.1993.11945678 · Cited by 1
Is regression of human atherosclerosis a clinical reality?
Simons, L. A. (1994) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.1994.tb138339.x · Cited by 1
Effect of Partial Ileal Bypass Surgery on Coronary Heart Disease
(1991) · New England Journal of Medicine · doi:10.1056/nejm199102213240813 · Cited by 1
Feeman, W. E. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.03.012 · Cited by 1
Does lipid-lowering therapy promote regression of coronary atheroma?
Leng, G. C., & Fowkes, F. G. R. (1994) · Europe PMC (PubMed Central) · Cited by 1
To statin or to non-statin in coronary disease-considering absolute risk is the answer
Rembold, C. M. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.04.007 · Cited by 1
Publications on Obesity Surgery for 1990
Shahi, B. (1991) · Obesity Surgery · doi:10.1381/096089291765561286 · Cited by 1
Statistical testing in a Linear Probability SpacePreprint
Rembold, C. M. (2019) · arXiv (Cornell University) · doi:10.48550/arxiv.1904.01491 · Cited by 1
Geller, N. L., Waclawiw, M. A., & Friedman, L. M. (2016) · Wiley eBooks · doi:10.1002/9781118445112.stat04987.pub2 · Cited by 1
Comment on: Long-term effects of bariatric surgery on cardiovascular risk factors in Singapore
Gupta, N., & Agrawal, H. (2021) · Singapore Medical Journal · doi:10.11622/smedj.2021148 · Cited by 1
Cannon, C. P., Ray, K. K., & D, E. B. M. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2006.05.038 · Cited by 1
Meyer, J., Bokisch, A., Darius, H., Heusch, G., Hort, W., Mohr-Kahaly, S., Rupprecht, H. J., & Voigtländer, T. (2000) · Springer eBooks · doi:10.1007/978-3-662-12156-6_20 · Cited by 1
Hepatobiliary manifestations in inflammatory bowel disease
Freudenberg, F., & Carey, M. C. (2007) · Springer eBooks · doi:10.1007/1-4020-4144-6_17 · Cited by 1
Seidel, D. (1994) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-78426-2_10 · Cited by 1
An Introduction to the Biochemistry and Biology of Blood Lipids and Lipoproteins
Patsch, J. R. (1994) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-78426-2_1 · Cited by 1
Hypercholesterolemia: Negotiating the Issues
LaRosa, J. C. (1993) · Medical science symposia series · doi:10.1007/978-94-011-1703-6_38
Koronarangiographie, Herzkatheterisierung und Angiokardiographie
Bestehorn, H., Roskamm, H., Petersen, J., Schnellbacher, K., & Görnandt, L. (2004) · Springer eBooks · doi:10.1007/978-3-642-18649-3_16
Cholesterol-Lowering Clinical Trials: Where Do We Go From Here?
Gotto, A. M. (1992) · The Argenteuil symposia · doi:10.1007/978-1-4471-1909-8_16
Brown, B. G., Zhao, X. Q., Poulin, D., & Albers, J. J. (1995) · Springer eBooks · doi:10.1007/978-1-4615-1959-1_1
Prevention of Atherosclerosis: Endothelial Function, Cholesterol, and Antioxidants
Vogel, R. A. (2007) · Springer eBooks · doi:10.1007/978-0-585-38141-1_5
An overview of fluvastatin clinical trials
Boven, A. J. V., & Pfister, P. (1996) · Developments in cardiovascular medicine · doi:10.1007/978-94-009-0291-6_8
Blankenhorn, D. H., & Hodis, H. N. (1994) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-78426-2_8
Mast cells and endothelial erosion: Implications for human atherothrombotic disease
Mäyränpää, M. I. (2007) · Työväentutkimus Vuosikirja
Seidel, D. (1994) · Springer eBooks · doi:10.1007/978-3-642-78637-2_16
Is there a place for visual assessment?
Cashin-Hemphill, L. (1996) · Developments in cardiovascular medicine · doi:10.1007/978-94-009-0143-8_5
Apheresis Methods in Hyperlipidemias
Şıvgın, S. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0515-7_15
Retardation of Progression of CoronalY Atherosclerosis
Vos, J. (1997) · EUR Research Repository (Erasmus University Rotterdam)
Klinik der koronaren Herzerkrankung III: Der Herzinfarkt im chronischen Stadium
Roskamm, H., Gick, M., Bubenheimer, P., Jander, N., & Schnellbacher, K. (2004) · Springer eBooks · doi:10.1007/978-3-642-18649-3_23
Pharmacologic Intervention: Lipid‐Lowering Agents
DePalma, R. G. (2005) · Vascular Surgery · doi:10.1002/9780470987094.ch40
Clinical Trials of Atherosclerosis Regression
Lewis, B. (1993) · Medical science symposia series · doi:10.1007/978-94-011-1703-6_30
How well does angiographic progression correlate with clinical events
Cashin-Hemphill, L. (1998) · Developments in cardiovascular medicine · doi:10.1007/978-94-011-5123-8_8
Bernard, J. A. (2009) · Europe PMC (PubMed Central)
Optimising Outcomes in Secondary Prevention of Coronary Heart Disease
LaRosa, J. C. (1997) · Disease Management & Health Outcomes · doi:10.2165/00115677-199702060-00003
Therapie der stabilen und instabilen Angina pectoris
Meyer, J., Bokisch, A., Darius, H., Heusch, G., Hort, W., Mohr-Kahaly, S., Rupprecht, H. J., & Voigtländer, T. (2000) · Springer eBooks · doi:10.1007/978-3-662-12156-6_19
Harvard Atherosclerosis Reversibility Project Group, Gibson, C. M., Stone, P. H., Pasternak, R. C., & Sacks, F. M. (1996) · Developments in cardiovascular medicine · doi:10.1007/978-94-009-0143-8_16
CCAIT Investigators, CAMPEAU, L. A., Lespérance, J., & Waters, D. D. (1996) · Developments in cardiovascular medicine · doi:10.1007/978-94-009-0143-8_15
Richter, W. O. (1994) · Fette Seifen Anstrichmittel · doi:10.1002/lipi.19940960104
Identification and Treatment of Women with Familial Hypercholesterolemia
Robinson, J. G. (2012) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-012-0231-7
Pitt, B. (1994) · Journal of Interventional Cardiology · doi:10.1111/j.1540-8183.1994.tb00490.x
Statins in Combinations: From ARBITER-6 HALTS to ACCORD—What Works?
Clearfield, M. B. (2010) · Current Atherosclerosis Reports · doi:10.1007/s11883-010-0142-3
Hypolipémiants et prévention des accidents vasculaires cérébraux. Méta-analyse
Corvol, J., Bouzamondo, A., Sirol, M., Hulot, J., Sanchez, P., & Lechat, P. (2003) · Therapies · doi:10.2515/therapie:2003006
Davignon, J. (1997) · Evidence-based Cardiovascular Medicine · doi:10.1016/s1361-2611(97)80027-9
Aggressive statin therapy for acute coronary syndromes
Liew, T. V., BChir, & Ray, K. K. (2007) · Current Cardiology Reports · doi:10.1007/bf02938378
Life-style Changes and Lipid Lowering-Reply
Barnard, R. J. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.1992.00400200145031
The Medical Management of the Patient with Claudication
Hirsch, A. T. (1997) · Journal of Vascular and Interventional Radiology · doi:10.1016/s1051-0443(97)70056-3
Efectividad del tratamiento hipocolesterolemiante a largo plazo
Núñéz-Cortés, J. M., & Walther, L. A. Á.-S. (2001) · Clínica e Investigación en Arteriosclerosis · doi:10.1016/s0214-9168(01)78780-3
Should we treat hypercholesterolaemia in the elderly?
Olbricht, C. (1991) · The Lancet · doi:10.1016/0140-6736(91)90790-v
Krupski, W. C. (1994) · Annals of Vascular Surgery · doi:10.1007/bf02018180
Approaches to the management of hypercholesterolemia
Florkowski, C. M., & Cramb, R. (1992) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.1992.tb01272.x
Ungelöste Aufgaben der kurativen Kardiologie: Stand 1991
Lichtlen, P. R. (1991) · Steinkopff eBooks · doi:10.1007/978-3-642-53795-0_20
Jejunoileal bypass for morbid obesity : studies of the long-term effects
Sylvan, A. (1995) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Effects of Lipid Lowering on Coronary Plaques and Coronary Events
Roberts, W. C. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00814-x
The Place of Alpha Blockers in the Antihypertensive Armamentarium
Carruthers, S. G. (1993) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1993.tb03954.x
Transplant Coronary Artery Disease
van der Linden, M. (1997)
Cooperative Heart Disease Trials
Geller, N. L., & Friedman, L. M. (2014) · Wiley StatsRef: Statistics Reference Online · doi:10.1002/9781118445112.stat04987
Klinik und Diagnostik der koronaren Herzkrankheit
Meyer, J., Bokisch, A., Darius, H., Heusch, G., Hort, W., Mohr-Kahaly, S., Rupprecht, H. J., & Voigtländer, T. (2000) · Springer eBooks · doi:10.1007/978-3-662-12156-6_18
Implementing expert systems into ongoing data analyses
Long, J. M., Slagle, J. R., Matts, J. P., & Srivastava, J. (1992) · Expert Systems with Applications · doi:10.1016/0957-4174(92)90006-e
Self-citationDevasia, T., Kodi, G., & Karkal, Y. R. (2014) · International Journal of Basic & Clinical Pharmacology · doi:10.5455/2319-2003.ijbcp20140226
Aktuelle Fragen zur Genese und Therapie der Atherosklerose
SCHETTLER, G. F. (1993) · Vieweg+Teubner eBooks · doi:10.1007/978-3-663-01942-8_1
LDL-cholesterol and coronary artery disease: where we've been, where we're going
Sumner, A. D. (2002)
Gotto, A. M., & Hoffman, A. S. (1994)
Shikora, S. A. (2015) · Obesity Surgery · doi:10.1007/s11695-015-1988-9
Neue Strategien in der Therapie der Fettstoffwechselstörung
SCHWANDT, P. (1991) · Steinkopff eBooks · doi:10.1007/978-3-642-53795-0_5
Oliver, M. (1991) · Springer eBooks · doi:10.1007/978-1-4471-1889-3_13
Clinical efficacy and safety of pravastatin treatment in symptomatic patients — the REGRESS trial
Jukema, J., van Boven, A., Reiber, J., Zwinderman, A., Kong, L. I., & Bruschke, A. V. (1996) · Developments in cardiovascular medicine · doi:10.1007/978-94-009-0143-8_8
Women and CHD: The Case for Prevention
Gordon, D. J. (2002) · Medical science symposia series · doi:10.1007/978-1-4615-1061-1_45
Coronary atherosclerosis intervention trials using serial quantitative angiography
Vos, J., & de Feyter, P. J. (1994) · Developments in cardiovascular medicine · doi:10.1007/978-94-015-8358-9_35
A blast from the past: lessons learned from a 40-year-old surgical randomized, controlled trial
Welbourn, R., & Pournaras, D. J. (2016) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2016.02.025
Drugs Affecting High-Density Lipoprotein and Triglyceride Metabolism
Gotto, A. M. (1993) · Medical science symposia series · doi:10.1007/978-94-011-1703-6_27
Drye, L. T., & Meinert, C. L. (2011) · Pharmaceutical Medicine · doi:10.1007/bf03256880
Hoshino, M., Soejima, Y., Maeda, Y., Ogata, T., Shimura, S., Kajimoto, Y., & Inoue, S. (2012) · Nippon Eiyo Shokuryo Gakkaishi · doi:10.4327/jsnfs.65.261
Lipids--how low do you go: plaque regression and passivation.
Pradka, L. R. (2000) · Journal of Cardiovascular Nursing · doi:10.1097/00005082-200010000-00005 · Cited by 1
Metadata
- Authors
- Buchwald, H., Varco, R. L., Matts, J. P., Long, J. M., Fitch, L. L., Campbell, G. S., Pearce, M. B., Yellin, A. E., Edmiston, W. A., Smink, R. D., Sawin, H. S., Campos, C. T., Hansen, B. J., Tuna, N., Karnegis, J. N., Sanmarco, M. E., Amplatz, K., Castaneda-Zuniga, W. R., Hunter, D. W., Bissett, J. K., Weber, F. J., Stevenson, J. W., Leon, A. S., & Chalmers, T. C.
- Affiliations
- University of Minnesota (US)
- University of Southern California (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1990-10-04
- Volume
- 323
- Issue
- 14
- Pages
- 946-955
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2331959986
- Cited by
- 1,001
- References
- 58
- Citations by year
- 2026: 3 · 2025: 2 · 2024: 3 · 2023: 9 · 2022: 5 · 2021: 20 · 2020: 11 · 2019: 16 · 2018: 10 · 2017: 11 · 2016: 22 · 2015: 15 · 2014: 17 · 2013: 12 · 2012: 17
- FWCI
- 84.71
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Surgery › Cardiac and Coronary Surgery Techniques
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Cholesterol and Lipid Metabolism
- Keywords
- partial ileal bypass, hypercholesterolemia, coronary artery disease, mortality, myocardial infarction, cholesterol lowering, LDL cholesterol, HDL cholesterol, first myocardial infarction, coronary artery bypass grafting, ejection fraction, long-term outcomes, nonfatal myocardial infarction
- MeSH terms
- Adult, Coronary Disease, Electrocardiography, Female, Follow-Up Studies, Humans, Hypercholesterolemia, Hyperlipidemias, Jejunoileal Bypass, Lipids, Male, Middle Aged, Ultrasonography, Multicenter Studies as Topic, Randomized Controlled Trials as Topic, Coronary Angiography
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review